MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
2.800
-0.250
-8.20%
After Hours: 2.830 +0.03 +1.06% 19:44 06/05 EDT
OPEN
3.010
PREV CLOSE
3.050
HIGH
3.010
LOW
2.700
VOLUME
136.13K
TURNOVER
--
52 WEEK HIGH
152.60
52 WEEK LOW
2.530
MARKET CAP
2.02M
P/E (TTM)
-0.0038
1D
5D
1M
3M
1Y
5Y
1D
Jaguar Animal Health Postpones 2026 Stockholder Meeting Again
TipRanks · 5d ago
Jaguar Health issues 64,668 unregistered shares to Streeterville in Series Q preferred exchange
PUBT · 5d ago
Weekly Report: what happened at JAGX last week (0525-0529)?
Weekly Report · 6d ago
Jaguar Health says research in ethnobotanical medicine helps advance crofelemer
TipRanks · 05/28 17:08
Jaguar Health advances extension phase of pivotal oral crofelemer trial in pediatric MVID patients
PUBT · 05/28 14:00
Jaguar Health regains compliance with Nasdaq Listing Rule
TipRanks · 05/27 15:43
Jaguar Health Regains Nasdaq Bid Price Compliance Status
TipRanks · 05/27 13:29
Jaguar Health regains Nasdaq compliance with $1 minimum bid price rule
PUBT · 05/27 13:08
More
About JAGX
Jaguar Health, Inc. is a commercial stage pharmaceuticals company. The Company is developing prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Its marketed drug Mytesi, (crofelemer 125 mg delayed-release tablets), is a first-in-class oral botanical drug product approved by the FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Its Canalevia-CA1, crofelemer delayed-release tablets drug, is an oral plant-based prescription product that is FDA conditionally approved to treat chemotherapy-induced diarrhea in dogs. It has an exclusive distribution agreement for the sale of Gelclair. It is developing a pipeline of prescription drug product candidates to address unmet needs in gastrointestinal health.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.